|Day Low/High||45.02 / 45.53|
|52 Wk Low/High||39.30 / 57.88|
Altria has moved up from Dividend Aristocrat to King, but new legislation could threaten the tobacco company and others.
The next six months set up very well for this name with mid-single-digits growth and consistency in earnings and cash flow.
Here we'll discuss the remaining two of the four Dividend Champions that, if all goes well, will soon become Kings.
I do think that this Fed Chair has learned to be cautious, in reflection of the policy errors made in late 2018.
Traders can learn from watching, as well as doing, and with the FOMC meeting landing, now's best time to practice the former.
Philip Morris International has paid rising dividends every year since its initial public offering in 2008, which occurred right in the middle of the Great Recession.
These five stocks have shared more than 60 consecutive annual dividend increases with their respective shareholders and their current dividend yields are greater than that for the S&P 500.
Black-market vaping has made the entire cannabis group toxic.
Dozens of beaten-up stocks could see tax-loss selling into the end of the year; here's a preview of some that could make up the next Tax Loss Selling Portfolio.
All kinds of government entities will be lining up against Juul Labs, lawsuits with big awards are coming and who knows what else as MO is in a downtrend with $35 as the next price target.
These 'bearish bets' are showing both technical and quantitative deterioration.
In the short term, Macy's is not likely to run afoul of dividend problems, but can management transform the company for long-term health? Few retailers have had such success.
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
It all comes down to matching my time frame.
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
As we have seen so far, in terms of market reaction, there is great reward at the point of sale in beating expectations.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
In this day and age, companies must be 'disruptors' or get left in the dust.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.